HOSPITAL NACIONAL PROFESOR ALEJANDRO POSADAS
🇦🇷Argentina
- Country
- 🇦🇷Argentina
- Ownership
- -
- Employees
- -
- Market Cap
- -
Clinical Trials
8
Active:0
Completed:6
Trial Phases
3 Phases
Phase 3:1
Phase 4:1
Not Applicable:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Not Applicable
2 (50.0%)Phase 3
1 (25.0%)Phase 4
1 (25.0%)Clinical and Funtional Caracteristics of Patients Admitted for Severe Pneumonia Due to COVID 19.
Completed
- Conditions
- Post-intensive Care SyndromeCOVID-19
- First Posted Date
- 2024-12-11
- Last Posted Date
- 2024-12-11
- Lead Sponsor
- Hospital Nacional Profesor Alejandro Posadas
- Target Recruit Count
- 51
- Registration Number
- NCT06727474
- Locations
- 🇦🇷
Ladislao Diaz Ballve, Haedo, Buenos Aires, Argentina
Prevalence of Hyponatremia in Dengue Infected Patients: Relationship With Systemic Inflammation.
Recruiting
- Conditions
- InflammationHyponatremiaDengue
- First Posted Date
- 2023-10-31
- Last Posted Date
- 2023-11-02
- Lead Sponsor
- Hospital Nacional Profesor Alejandro Posadas
- Target Recruit Count
- 530
- Registration Number
- NCT06109532
- Locations
- 🇦🇷
Ladislao Diaz Ballve, Haedo, Buenos Aires, Argentina
🇦🇷Hospital Posadas, Buenos Aires, Argentina
Amniotic Membrane Treatment for Hyposecretory Dry Eye
Phase 3
Completed
- Conditions
- Dry Eye SyndromesSjogren Syndrome With Keratoconjunctivitis
- First Posted Date
- 2022-10-28
- Last Posted Date
- 2022-10-28
- Lead Sponsor
- Hospital Nacional Profesor Alejandro Posadas
- Target Recruit Count
- 37
- Registration Number
- NCT05598242
- Locations
- 🇦🇷
Hospital Nacional Posadas, El Palomar, Buenos Aires, Argentina
🇦🇷Hospital Nacional Prof. A. Posadas, El Palomar, Buenos Aires, Argentina
🇦🇷Hospital Nacional Profesor A. Posadas, El Palomar, Buenos Aires, Argentina
Role of Information and Communication Technologies for Health Support in Inflammatory Bowel Diseases: The DAMASCO Trial
- Conditions
- Knowledge, Attitudes, PracticeQuality of LifeInflammatory Bowel DiseasesTreatment Adherence and Compliance
- First Posted Date
- 2021-05-20
- Last Posted Date
- 2021-05-21
- Lead Sponsor
- Hospital Nacional Profesor Alejandro Posadas
- Target Recruit Count
- 351
- Registration Number
- NCT04893928
- Locations
- 🇦🇷
Miguel Angel Puga Tejada, Buenos Aires, Argentina
Efficacy of Different Treatments for the Intensive Care Unit Acquired Weakness
Not Applicable
Completed
- Conditions
- Muscle WeaknessRehabilitation
- First Posted Date
- 2020-11-03
- Last Posted Date
- 2020-11-03
- Lead Sponsor
- Hospital Nacional Profesor Alejandro Posadas
- Target Recruit Count
- 18
- Registration Number
- NCT04613908
- Prev
- 1
- 2
- Next
News
No news found